Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors
Year: 2021
Type: article
Source: Cancer Research
Institution: AbbVie (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: AbbVie
OpenAlex ID: W3134770103
